Molecular Inflammatory Mediators in Peripheral Nerve Degeneration and Regeneration

NeuroImmunoModulation - Tập 17 Số 5 - Trang 314-324 - 2010
Carlos R. Cámara-Lemarroy1, F. Garza2, Nancy Esthela Fernández-Garza2
1Department of Physiology, Universidad Autónoma de Nuevo León, School of Medicine, Monterrey, Mexico. [email protected]
2Department of Physiology, Universidad Autónoma de Nuevo León, School of Medicine, Monterrey, Mexico

Tóm tắt

Wallerian degeneration, the self-destructive set of cellular and molecular processes by which degenerating axons and myelin are cleared after injury, is initiated by macrophages and Schwann cells. Molecular inflammatory mediators such as cytokines (IL-1, IL-6, IL-10, and TNF-α, among others), transcription factors (NF-ĸB, c-Jun), the complement system and arachidonic acid metabolites have been shown to modulate these processes in various studies. However, the exact role that each of these mediators plays during axonal degeneration and regeneration has not been fully established. Understanding the molecular basis of these interactions between the immune system and peripheral nerve injury would open the possibility of targeting these inflammatory mediators as therapeutic interventions. In this review we attempt to integrate the current evidence generated around this issue, and to explore the therapeutic possibilities that arise.

Từ khóa


Tài liệu tham khảo

10.1111%2Fj.1750-3639.1999.tb00229.x

10.1016%2Fj.jns.2004.03.008

10.1111%2Fj.1750-3639.1997.tb01060.x

10.1002%2F1097-4598%282000%29999%3A9%3C%3A%3AAID-MUS7%3E3.0.CO%3B2-F

10.1016%2F0165-5728%2894%2990209-7

10.1016%2Fj.expneurol.2006.05.024

10.1046%2Fj.1529-8027.2002.02002.x

10.1007%2FBF00939244

10.1038%2Fnrn752

10.2353%2Fajpath.2007.070166

10.1016%2Fj.molimm.2006.03.007

10.1196%2Fannals.1332.010

10.1093%2Fhmg%2Fddh029

10.1016%2FS0162-3109%2897%2900073-8

10.1002%2Fjnr.490310409

10.1016%2F0022-510X%2891%2990162-Z

10.1023%2FA%3A1007012916530

10.2353%2Fajpath.2008.070660

10.1002%2Fana.20546

10.1523%2FJNEUROSCI.5623-06.2007

10.1002%2Fana.410300205

10.1378%2Fchest.118.2.503

10.1159%2F000087104

10.1378%2Fchest.117.4.1162

10.1016%2Fj.neulet.2003.12.018

10.2174%2F1389450043345308

10.1016%2FS1359-6101%2802%2900026-6

10.1038%2F330658a0

10.1016%2F0165-5728%2892%2990176-L

10.1016%2Fj.bbrc.2007.10.198

10.1002%2Fcne.21149

10.1016%2Fj.neulet.2004.09.075

10.1016%2Fj.orthres.2005.01.012

10.1002%2Fjor.1100170514

10.1002%2Fmus.20924

10.1016%2FS0006-8993%2802%2903806-4

10.1093%2Fbrain%2Fawh407

10.1016%2FS0165-5728%2898%2900121-0

10.1007%2Fs00401-002-0541-9

10.1016%2FS0165-5728%2800%2900262-9

10.1016%2F0165-5728%2892%2990085-Y

10.1016%2Fj.mcn.2005.10.011

10.1007%2Fs10254-003-0012-2

10.1016%2Fj.neuroscience.2008.01.014

10.1016%2Fj.neulet.2007.11.003

10.1016%2Fj.bbi.2006.10.003

10.1016%2FS0165-5728%2899%2900132-0

10.1111%2Fj.1460-9568.1996.tb01237.x

10.1084%2Fjem.183.6.2627

10.1002%2F%28SICI%291098-1136%28199905%2926%3A3%3C191%3A%3AAID-GLIA1%3E3.0.CO%3B2-%23

10.1111%2Fj.1460-9568.2006.05155.x

10.1002%2Fjnr.490300412

10.1016%2FS0165-5728%2803%2900179-6

10.1083%2Fjcb.133.1.159

10.1046%2Fj.1460-9568.1998.00277.x

10.1016%2FS0165-5728%2899%2900154-X

10.1002%2F%28SICI%291097-4547%2819960115%2943%3A2%3C254%3A%3AAID-JNR13%3E3.0.CO%3B2-6

10.1002%2F%28SICI%291097-4547%2819980215%2951%3A4%3C489%3A%3AAID-JNR8%3E3.0.CO%3B2-8

10.1016%2Fj.expneurol.2004.02.011

10.1016%2Fj.tins.2005.06.008

10.1002%2Fjnr.1158

10.1016%2Fj.neulet.2007.01.086

10.1038%2Fsj.cdd.4401837

10.2174%2F1568010023344698

10.1016%2FS0006-2952%2898%2900214-7

10.1007%2Fs00221-005-2318-6

10.1006%2Fexnr.1997.6585

10.1007%2Fs12264-007-0046-6

10.1111%2Fj.1460-9568.2005.04379.x

10.1093%2Fbja%2Fael209

10.1016%2Fj.jbspin.2004.01.010

10.1096%2Ffj.08-109355

10.1097%2F00001756-200107200-00008

10.1016%2FS0165-5728%2801%2900306-X

10.1016%2Fj.jneuroim.2006.01.004

10.1016%2FS0006-8993%2898%2900380-1

10.1186%2F1471-2202-7-4

10.1016%2Fj.jns.2007.10.004

10.1523%2FJNEUROSCI.3127-04.2005

10.1002%2Fglia.1113

10.1038%2Fnn995

10.1111%2Fj.1460-9568.1995.tb01128.x

10.1186%2F1471-2202-5-9

10.1002%2Fcne.903590411

10.1016%2F0304-3940%2894%2990886-9

10.1016%2F0304-3940%2893%2990188-Q

10.1002%2Fglia.20761

10.1002%2F%28SICI%291097-4547%2819961001%2946%3A1%3C114%3A%3AAID-JNR14%3E3.0.CO%3B2-5

10.4067%2FS0716-97602007000200001

10.1073%2Fpnas.1432609100

10.1074%2Fjbc.M607277200

10.1111%2Fj.1471-4159.2008.05353.x

10.1111%2Fj.1471-4159.2007.04524.x

10.1016%2Fj.bbrc.2006.09.108

10.1523%2FJNEUROSCI.3027-07.2007

10.2174%2F1389203023380585

10.1016%2FS0006-2952%2802%2901422-3

10.2174%2F1568010054022051

10.1016%2Fj.brainresrev.2006.02.002

10.1016%2Fj.neulet.2008.02.072

10.1046%2Fj.1460-9568.2002.01940.x

10.1016%2Fj.neulet.2004.03.040

10.1016%2FS0306-4522%2899%2900365-6

10.1186%2F1471-2377-6-1

10.1016%2FS0306-4522%2803%2900495-0

10.1081%2FIMM-120022973

10.1016%2FS0165-5728%2800%2900372-6

10.1002%2Fglia.10349

10.1523%2FJNEUROSCI.4353-06.2007

10.1016%2FS0197-4580%2802%2900021-0

10.1186%2F1749-7221-3-25

10.1016%2FS0306-4522%2802%2900764-9

10.1081%2FIMM-120016238

10.1016%2FS1044-7431%2803%2900241-0

10.1093%2Fbrain%2Fawn188

10.1002%2Fglia.20766

10.1016%2Fj.expneurol.2005.04.016

10.1016%2Fj.cps.2005.05.003

10.1016%2Fj.jneuroim.2008.04.027

10.1016%2Fj.neulet.2008.05.081

10.1016%2F0197-0186%2895%2900121-2

10.1016%2FS0006-8993%2800%2902190-9

10.1111%2Fj.1529-8027.2007.00148.x

10.1097%2F00001756-200104170-00043

Thông tin
Thông tin xuất bản

NeuroImmunoModulation

Tập 17 Số 5

314-324

Thông tin tác giả